Abstract
Over the past 40 years, a growing evidence base has established an association between lithium treatment and reduced rates of suicide in patients with mood disorders. This chapter examines the evidence surrounding this link, from early observational reports to randomized controlled trials. Methodological challenges in conducting this research are discussed. We also illustrate how the use of meta-analysis can overcome some of these limitations and demonstrate a convincing link between lithium treatment and reduced suicide rates. Finally, possible mechanisms of action by which lithium may offer suicide protective effects are explored, indicating the interesting possibility of an independent suicide-preventative action.
It appears that the introduction of lithium treatment in the 1970s was the most recent important breakthrough in the prevention of suicide in bipolar disorder.
(Latalova et al., 2014, p. 113)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Adida M, Jollant F, Clark L, Guillaume S, Goodwin GM, Azorin J-M, Courtet P (2015) Lithium might be associated with better decision-making performance in euthymic bipolar patients. Eur Neuropsychopharmacol 25:788–797
Ahrens B, Müller-Oerlinghausen B (2001) Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry 34:132–136
Angst J, Angst F, Gerber-Werder R, Gamma A (2005) Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years’ follow-up. Arch Suicide Res 9:279–300
Bakst S, Braun T, Hirshberg R, Zucker I, Shohat T (2014) Characteristics of suicide completers with a psychiatric diagnosis before death: a post-mortem study of 98 cases. Psychiatry Res 220:556–563
Baldessarini RJ, Tondo L (2009) Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants. Pharmacopsychiatry 42:72–75
Baldessarini RJ, Tondo L, Hennen J (1999) Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 60:77–84
Baldessarini RJ, Pompili M, Tondo L, Tsapakis E, Soldani F, Faedda GL, Hennen J (2005) Antidepressants and suicidal behaviour: are we hurting or helping? Clin Neuropsychiatry 2:73–75
Baldessarini RJ, Tondo L, Davis P et al (2006) Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 8:625–639
Barraclough BM (1972) Suicide prevention, recurrent affective disorder and lithium. Br J Psychiatry 121:391–392
Barraclough B, Bunch J, Nelson B, Sainsbury P (1974) A hundred cases of suicide: clinical aspects. Br J Psychiatry 125:355–373
Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60:392–400
Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 64:1013–1024
Cavanagh JT, Carson AJ, Sharpe M, Lawrie SM (2003) Psychological autopsy studies of suicide: a systematic review. Psychol Med 33:395–405
Cipriani A, Pretty H, Hawton K, Geddes JR (2005) Lithium in the prevention of suicidal behaviour and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 162:1805–1819
Cipriani A, Hawton K, Stockton S, Geddes JR (2013) Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 346:3646
Collins JC, McFarland BH (2008) Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord 107:23–28
Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C (1990) Long-term lithium and mortality. Lancet 335:1347
Department of Health (2002) National suicide prevention strategy for England. Department of Health, London
Egger M, Smith GD (1998) Bias in location and selection of studies. BMJ 316:61–66
Geddes J, Burgess S, Hawton K, Jamison K, Goodwin GM (2004) Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 161:217–222
Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E (2010) BALANCE investigators and collaborators. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomized open-label trial. Lancet 375:385–395
Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 290:1467–1473
Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T (1996) Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. J Affect Disord 40:179–190
Greil W, Ludwig-Mayerhofer W, Erazo N, Schöchlin C, Schmidt S, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling T (1997a) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders—a randomised study. J Affect Disord 43:151–161
Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GA, Sauer H, Tegeler J, Wetterling J (1997b) Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study. Eur Arch Psychiatry Clin Neurosci 247:42–50
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S, on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorder (2013) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 14:154–219
Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ (2007) Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry 68:380–383
Harris EC, Barraclough B (1997) Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 170:205–228
Isometsä E, Sund R, Pirkola S (2014) Post-discharge suicides of inpatients with bipolar disorder in Finland. Bipolar Disord 16:867–874
Kalkman HO (2011) Circumstantial evidence for a role of glutamine-synthetase in suicide. Med Hypotheses 76:905–907
Kessler RC, Berglund P, Borges G, Nock M, Wang PS (2005) Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990–1992 to 2001–2003. JAMA 293(20):2487–2495
Khan A, Khan SR, Hobus J, Faucett J, Mehra V, Giller EL, Rudolph RL (2011) Differential pattern of response in mood symptoms and suicide risk measures in severely ill depressed patients assigned to citalopram with placebo or citalopram combined with lithium: role of lithium levels. J Psychiatr Res 45:1489–1496
Kovacsics CE, Gottesman II, Gould TD (2009) Lithium’s antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies. Annu Rev Pharmacol Toxicol 49:175–198
Latalova K, Kamaradova D, Prasko J (2014) Suicide in bipolar disorder: a review. Psychiatr Danub 26:108–114
Lauterbach E, Felber W, Müller-Oerlinghausen B, Ahrens B, Bronisch T, Meyer T, Kilb B, Lewitzka U, Hawellek B, Quante A, Richter K, Broocks A, Hohagen F (2008) Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand 118:469–479
Lee B-H, Kim Y-K (2011) Potential peripheral biological predictors of suicidal behavior in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 35:842–847
Malhi GS (2015) Lithium therapy in bipolar disorder: a balancing act? Lancet 386:415–416, (published online 20 May 2015) [http://dx.doi.org/10.1016/S0140-6736(14)62123-1]
Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, Hopwood M, Lyndon B, Mulder R, Murray G, Porter R (2015) Singh AB Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 49:1087–1206
Mann JJ (2002) A current perspective of suicide and attempted suicide. Ann Intern Med 136:302–311
McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR (2012) Lithium toxicity profile: a systematic review and meta-analysis. Lancet 379:721–728
Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer J-P, Potkin S (2003) Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003(60):82–91
Mühlbauer HD, Müller-Oerlinghausen B (1985) Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man. J Neural Transm 61:81–94
Müller-Oerlinghausen B, Lewitzka U (2010) Lithium reduces pathological aggression and suicidality: a mini-review. Neuropsychobiology 62:43–49
Müller-Oerlinghausen B, Müser-Causemann B, Volk J (1992) Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 25:261–269
Müller-Oerlinghausen B, Wolf T, Ahrens B, Schou M, Grof E, Grof P et al (1994) Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-treated patients. Acta Psychiatr Scand 90:295–297
Müller-Oerlinghausen B, Wolf T, Ahrens B, Glaenz T, Schou M, Grof E et al (1996) Mortality of patients who dropped out from regular lithium prophylaxis: a collaborative study by the International Group for the Study of Lithium-treated patients (IGSLI). Acta Psychiatr Scand 94:344–347
National Institute for Health and Clinical Excellence (2014) Bipolar disorder: the assessment and managementof bipolar disorder in adults, children and young people in primary and secondary care http://www.nice.org.uk/
Nordentoft M, Mortensen PB, Pedersen CB (2011) Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry 68:1058–1064
Ohmura Y, Tsutsui-Kimura I, Kumamoto H, Minami M, Izumi T, Yamaguchi T, Yoshida T, Yoshioka M (2012) Lithium, but not valproic acid or carbamazepine, suppresses impulsive-like action in rats. Psychopharmacology 219:421–432
Oquendo MA, Galfalvy HC, Currier D, Grunebaum MF, Sher L, Sullivan GM, Burke AK, HarkavyFriedman J, Sublette ME, Parsey RV, Mann JJ (2011) Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behaviour. Am J Psychiatry 168:1050–1056
Ougrin D, Tranah T, Stahl D, Moran P, Asarnow JR (2015) Therapeutic interventions for suicide attempts and self-harm in adolescents: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 54:97–107
Pfennig A, Bauer M (2013) S3guidelines on bipolar disorders are contemporary and important instruments for clinical practice. Nervenarzt 84:874–875
Prien RF, Klett CJ, Caffey EM Jr (1973a) Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry 29:420–425
Prien RF, Caffey EM Jr, Klett CJ (1973b) Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 28:337–341
Rihmer Z, Gonda X (2013) Pharmacological prevention of suicide in patients with major mood disorders. Neurosci Biobehav Rev 37:2398–2403
Saunders KE, Hawton K (2009) The role of psychopharmacology in suicide prevention. Epidemiol Psichiatr Soc 18:172–178
Schaffer A, Isometsa ET, Tondo L, Moreno DH, Turecki G, Reis C, Cassidy F, Sinyor M, Azorin J-M, Kessing LV, Ha K, Goldstein T, Weizman A, Beautrais A, Chou Y-H, Diazgranados N, Levitt AJ, Zarate CA Jr, Rihmer Z, Yatham LN (2015) International society for bipolar disorders task force on suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord 17:1–16
Shine B, McKnight RF, Leaver L, Geddes JR (2015) Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet 386:1–7, (published online May 21.) [http://dx.doi.org/S0140-6736(14)61842-0.]
Simon GE, Savarino J, Operskalski B, Wang PS (2006) Suicide risk during antidepressant treatment. Am J Psychiatry 163:41–47
Toffol E, Hätönen T, Tanskanen A, Lönnqvist J, Wahlbeck K, Joffe G, Tiihonen J, Haukka J, Partonen T (2015) Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: a nationwide registry-based prospective cohort study. J Affect Disord 183:159–165
Tondo L, Baldessarini RJ (2007) Suicidal risks among 2826 Sardinian major affective disorder patients. Acta Psychiatr Scand 116:419–428
Tondo L, Baldessarini RJ (2009) Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psichiatr Soc 18:179–183
Tondo L, Baldessarini RJ, Hennen J, Floris G, Silvetti F, Tohen M (1998) Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry 59:405–414
Tondo L, Isacsson G, Baldessarini RJ (2003) Suicide in bipolar disorder: risk and prevention. CNS Drugs 17:491–511
Tondo L, Albert MJ, Baldessarini RJ (2006) Suicide rates in relations to health care access in the United States: an ecological study. J Clin Psychiatry 67:517–523
US Department of Health Human Services (2001) National strategy for suicide prevention: goals and objectives for action. US Department of Health and Human Services, Public Health Service, Washington, DC
WHO (2014) Preventing suicide: a global imperative. http://www.who.int/mental_health/suicide-prevention/world_report_2014/en/
Wolf T, Müller-Oerlinghausen B, Ahrens B, Grof P, Schou M, Felber W, Grof E, Lenz G, Nilsson A, Simhandl C, Thau K, Vestergaard P, Wolf R (1996) How to interpret findings on mortality of long-term lithium treated manic-depressive patients?! Critique of different methodological approaches. J Affect Disord 39:127–132
Young A (2014) Lithium and suicide. Lancet Psychiatry 6:483–484
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Jones, H., Geddes, J., Cipriani, A. (2017). Lithium and Suicide Prevention. In: Malhi, G., Masson, M., Bellivier, F. (eds) The Science and Practice of Lithium Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-45923-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-45923-3_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45921-9
Online ISBN: 978-3-319-45923-3
eBook Packages: MedicineMedicine (R0)
